0001140361-19-018090.txt : 20191007
0001140361-19-018090.hdr.sgml : 20191007
20191007193920
ACCESSION NUMBER: 0001140361-19-018090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191007
FILED AS OF DATE: 20191007
DATE AS OF CHANGE: 20191007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant V Luxco S.a r.l.
CENTRAL INDEX KEY: 0001786141
STATE OF INCORPORATION: N4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141688
BUSINESS ADDRESS:
STREET 1: 15, BOULEVARD F.W. RAIFFEISEN
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2411
BUSINESS PHONE: (415) 801-8100
MAIL ADDRESS:
STREET 1: 15, BOULEVARD F.W. RAIFFEISEN
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V, LLC
CENTRAL INDEX KEY: 0001619298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141689
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2215
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V GP-GP (Canada), Inc.
CENTRAL INDEX KEY: 0001619297
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141690
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2215
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V (Canada), L.P.
CENTRAL INDEX KEY: 0001716490
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141691
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (650) 843-5000
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP
CENTRAL INDEX KEY: 0001612235
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141692
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P.
CENTRAL INDEX KEY: 0001589095
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141693
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P.
CENTRAL INDEX KEY: 0001589098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141694
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V, L.P.
CENTRAL INDEX KEY: 0001589097
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141695
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
form4.xml
FORM 4
X0306
4
2019-10-07
0001781983
Aprea Therapeutics, Inc.
APRE
0001786141
Versant V Luxco S.a r.l.
15 BOULEVARD F.W. RAIFFEISEN
2411 LUXEMBOURG
N4
L-2411
LUXEMBOURG
true
0001619298
Versant Ventures V, LLC
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
0001619297
Versant Ventures V GP-GP (Canada), Inc.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
0001716490
Versant Ventures V (Canada), L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
0001612235
Versant Venture Capital V (Canada), LP
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
0001589095
Versant Affiliates Fund V, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
0001589098
Versant Ophthalmic Affiliates I, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
0001589097
Versant Venture Capital V, L.P.
ONE SANSOME STREET
SUITE 3630
SAN FRANCISCO
CA
94104
true
Common Stock
2019-10-07
4
C
0
1993658
A
2006328
D
Common Stock
2019-10-07
4
C
0
512995
A
2519323
D
Common Stock
2019-10-07
4
P
0
333333
15
A
333333
I
See footnotes
Series B Convertible Preferred Stock
2019-10-07
4
C
0
1993658
D
Common Stock
1993658
0
D
Series C Convertible Preferred Stock
2019-10-07
4
C
0
512995
D
Common Stock
512995
0
D
These shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Common Stock ("Shares"), on a 1-for-1 basis, immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date.
These Shares and Preferred Stock are directly held by Versant V Luxco S.a r.l.
Versant V Luxco S.a r.l. is majority owned by Versant Venture Capital V, L.P. and minority owned by Versant Ophthalmic Affiliates Fund I, L.P., Versant Affiliates Fund V, L.P. (together with Versant Venture Capital V, L.P. and Versant Ophthalmic Affiliates Fund I, L.P, the "Versant Funds") and Versant Venture Capital V (Canada) LP ("Versant Canada"). Versant Ventures V, LLC ("Ventures V") is the general partner of each of the Versant Funds. Versant Ventures V GP-GP (Canada), Inc. is the general partner of Versant Ventures V (Canada), L.P., which is the general partner of Versant Canada. Each of the Versant Funds, Versant Canada, Versant Ventures V (Canada), L.P., Versant Ventures V GP-GP (Canada), Inc. and Ventures V may be deemed to indirectly beneficially own the shares beneficially owned by Versant V Luxco S.a r.l., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein.
These Shares are directly held by Versant Vantage I, L.P. Versant Vantage I GP-GP, LLC is the general partner of Versant Vantage I GP, L.P., which is the general partner of Versant Vantage I, L.P. Each of Versant Vantage I GP-GP, LLC and Versant Vantage I GP, L.P. may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage I, L.P., but each disclaims such beneficial ownership except to the extent of its pecuniary interest therein.
Samuel D. Colella ("Colella"), William J. Link ("Link"), Bradley Bolzon, Ph.D ("Bolzon"), Kirk G. Nielsen ("Nielsen"), Thomas Woiwode ("Woiwode"), Jerel C. Davis ("Davis") and Robin L. Praeger ("Praeger") are managing directors of Ventures V. Bolzon, Woiwode, Davis, Praeger, and Clare Ozawa ("Ozawa") are managing directors of Versant Vantage I GP-GP, LLC. Each of Colella, Link, Bolzon, Nielsen, Woiwode, Praeger, Davis and Ozawa disclaim beneficial ownership of the Shares reported herein, except to the extent of his or her pecuniary interest therein.
/s/ Versant V Luxco S.a r.l. By: Robin L. Praeger Its: Manager
2019-10-07
/s/ Versant Ventures V, LLC By: Robin L. Praeger Its: Managing Director
2019-10-07
/s/ Versant Ventures V GP-GP (Canada), Inc. By: Robin L. Praeger Its: Director
2019-10-07
/s/ Versant Ventures V (Canada), L.P. By: Versant Ventures V GP-GP (Canada), Inc. Its: General Partner
By: Robin L. Praeger Its: Director
2019-10-07
/s/ Versant Venture Capital V (Canada) LP By: Versant Ventures V (Canada), L.P. Its: General Partner
By: Versant Ventures V GP-GP (Canada), Inc. Its: General Partner By: Robin L. Praeger Its: Director
2019-10-07
/s/ Versant Affiliates Fund V, L.P. By: Versant Ventures V, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director
2019-10-07
/s/ Versant Ophthalmic Affiliates Fund I, L.P. By: Versant Ventures V, LLC Its: General Partner By: Robin L. Praeger
Its: Managing Director
2019-10-07
/s/ Versant Venture Capital V, L.P. By: Versant Ventures V, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director
2019-10-07